• no-js

The mission of the MRC Weatherall Institute of Molecular Medicine (WIMM) is to undertake internationally competitive research into the processes underlying normal cell and molecular biology and to determine the mechanisms by which these processes are perturbed in inherited and acquired human diseases. It is also our mission to translate this research to improve human health. The WIMM is uniquely placed among biomedical institutes throughout the world in its pioneering vision of combining outstanding clinical research with excellent basic science. The WIMM Faculty currently includes an equal mixture of scientists and clinicians working together and in collaboration with the National Institute of Health Research, the NHS and commercial companies with the aim of improving the diagnosis and treatment of human diseases. The major topics of current research include haematology, immunology, stem cell biology, oncology and inherited human genetic diseases. The Institute benefits from strategic support from the MRC.

MRC logo

The Institute values communication with members of the broader scientific community and the general public and with the support of the Medical Research Council (MRC) we have commissioned three short videos to explain our mission.

News

MRC WIMM Centre for Computational Biology is officially opened by Sir John Savill

MRC WIMM Centre for Computational Biology is officially opened by Sir John Savill

Posted 08/12/2016

The MRC WIMM Centre for Computational Biology is a new purpose-built facility at the MRC Weatherall Institute of Molecular Medicine (WIMM) which brings together experts in analysis of large computational datasets. The new Centre was officially opened by Sir John Savill, Chief Executive of the Medical Research Council, during a ceremony held at the WIMM on Wednesday 7th December. Building work on the new Centre started in November 2015, funded ...

 

MRC WIMM raises grand total of £2551.14 for Oxford Homeless Medical Fund

MRC WIMM raises grand total of £2551.14 for Oxford Homeless Medical Fund

Posted 21/12/2016

Every year, the MRC WIMM organises a series of fund-raising events in aid of a local charity, including a summer quiz, a raffle, and sales of home-grown plants and home-made cakes. This autumn, the Institute organised a craft fair selling gifts, home-made jams, chutneys and cakes, with proceeds going to this year's nominated charity: the Oxford Homeless Medical Fund.  The Oxford Homeless Medical Fund (OHMF), now managed by Oxford Homeless ...

News Archive

 

Vacancies

Postdoctoral Computational Cancer Biologist ref: 127566

Posted 21/02/2017

Grade 7: £31,076 - £38,183 with a discretionary range to £41,709 p.a THIS IS A RE-ADVERTISEMENT.  PREVIOUS APPLICANTS NEED NOT APPLY Applications are invited for a Computational Cancer Biologist in a programme funded by the Wellcome Trust. We are seeking a team player to analyse RNA-seq data from human cancers within the group of Professor Terry Rabbitts based at the MRC Weatherall Institute of Molecular Medicine (WIMM). The objective is to ...

Other Vacancies

WIMM Blog

Stopping the spread: towards new treatments for childhood cancer

stopsign_thumb

Cancers of the blood, or leukaemias, that involve mutations in a gene called Mixed Lineage Leukaemia (MLL) have a very poor prognosis and are particularly prevalent in young children. Due to the aggressive nature of this type of cancer, there is an acute need for the development of more effective therapies to help treat the children who suffer from this devastating condition. Professor Thomas Milne’s group in the MRC Molecular Haematology Unit recently published an article in Cell Reports detailing the mechanisms by which MLL translocations may drive malignancy and exploring the potential use of small molecule inhibitors to mediate this. In this blog post, two of the authors on the paper (Jon Kerry and Laura Godfrey) describe their findings.

WIMM Blog Archive